Core Insights - Auxly Cannabis Group Inc. reported strong financial results for Q4 and the full year 2025, highlighting significant growth in net revenue and adjusted EBITDA, alongside improved gross margins [2][4][11]. Financial Performance - Net revenue for Q4 2025 reached $40.1 million, a 16% increase from Q4 2024, driven by higher volume and pricing across product categories [7]. - For the full year 2025, net revenue was $151.5 million, up 24% from $122.3 million in 2024 [7][24]. - Adjusted EBITDA for Q4 2025 was $12.5 million, a 14% increase year-over-year, while for the full year, it was $43.8 million, reflecting a 64% growth compared to 2024 [12][24]. - Gross Margin on Finished Cannabis Inventory Sold improved to 56% in Q4 2025 from 54% in Q4 2024, and for the full year, it was 54%, up from 46% in 2024 [8][24]. Cost Management - Selling, general and administrative (SG&A) expenses for Q4 2025 were $11.7 million, a 26% increase from the previous year, while total SG&A for the year was $43.4 million, up 22% [9][24]. - The company maintained a strong adjusted EBITDA margin of 31% in Q4 2025, compared to 32% in Q4 2024 [12]. Profitability - Net income for Q4 2025 was $0.9 million, down from $4.4 million in Q4 2024, primarily due to realized fair value losses on inventory [10]. - For the full year, net income was $41.9 million, a significant improvement from a loss of $16.3 million in 2024, aided by a deferred tax recovery and gains from the settlement of the Imperial Debenture [11][24]. Market Position and Strategy - Auxly was recognized as the 3 Canadian Licensed Producer by market share, with its flagship brand, Back Forty, being the top cannabis brand in Canada for 2025 [2][4]. - The company launched a new premium-tier brand, South Point, in Alberta and Ontario, indicating a focus on product innovation and market expansion [2]. Future Outlook - Auxly plans to allocate $10 to $12 million towards capital projects in 2026 to enhance quality and throughput at Auxly Leamington, preparing for direct international distribution [5][17]. - The company is actively evaluating international export opportunities, supported by its strong brands and scalable production capabilities [15][18].

Auxly Cannabis Group Conference Call Summary Company Overview - Auxly Cannabis Group is a publicly traded Canadian cannabis company headquartered in Toronto, trading on the TSX and OTCQB exchanges [2][3] - The company has a team of 410 members and specializes in the cultivation and manufacturing of cannabis products [3][4] - Auxly is the third largest producer of cannabis products in Canada, holding a 6.2% market share [4] Financial Performance - For the trailing 12 months as of Q2, Auxly generated $139 million in net operating revenue, $38 million in adjusted EBITDA, and $28 million in net income [5] - Q2 2025 financials showed a record $38.8 million in net revenue, a 33% year-over-year increase, and expanded gross margins to 52%, an 11 percentage point improvement [15] - Adjusted EBITDA for Q2 was $11.6 million, a 123% improvement year-over-year, resulting in a 30% EBITDA margin [15] - The company generated $8.3 million in net income and $4 million in cash flow from operations during Q2 [16] - Over the 12-month period, Auxly achieved a 56% conversion rate of EBITDA to cash flow, generating $21.5 million of cash flow on $38 million of EBITDA [16] Market Dynamics - The Canadian cannabis market is growing, with increasing consumer preference for regulated sources over the illicit market [5][6] - Weaker players exiting the market have improved pricing dynamics for producers like Auxly [6] - The company aims to focus on domestic success while also eyeing international market opportunities [6][7] Product Portfolio and Innovation - Auxly's flagship brand, Back Forty, is the number one brand in cannabis by dollars sold and is present in 97% of retail locations [4] - The company focuses on key product categories: dried flower, pre-rolls, and vapes, which collectively account for about 90% of market sales [4] - Back Forty is growing at a rate of 91% in the dried flower category and 41% in pre-rolls on a rolling 12-month basis [10][11] - Auxly Charlottetown is recognized for its innovation in the vape segment, holding a 23% market share in that category [13] Strategic Partnerships - Auxly has a strategic partnership with Imperial Brands, which owns 19.9% of the company and supports its growth into international markets [7][8] - The partnership has facilitated a five-year R&D collaboration to enhance pre-roll filling and packaging capabilities [11] Operational Excellence - Auxly Leamington, a 1.1 million square foot cultivation facility, is designed specifically for cannabis production and is one of the largest in the world [9] - The facility produces about 100,000 kilograms of high-quality dried flowers annually, with a target of 85% of production going to B2C sales [20] - The company aims to improve output by 8-10% annually through capital-light initiatives [24] Balance Sheet and Future Outlook - Auxly recently recapitalized its balance sheet, eliminating $21 million of debt and transforming its working capital from a deficit to a pro forma surplus of $35 million [17] - The company is focused on prudent capital allocation to high-return opportunities while maintaining profitability and cash flow [18][29] - Auxly is committed to navigating the evolving regulatory environment for international markets with caution and transparency [30] Conclusion - Auxly Cannabis Group is positioned for continued growth in a stable and expanding market, with a strong focus on product innovation, operational excellence, and strategic partnerships [18]